Notice: This company has been marked as potentially delisted and may not be actively trading. Genesis Healthcare (GEN) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipTrends GEN vs. ADSK, TEAM, SQ, NTES, DDOG, SNOW, EA, HUBS, VEEV, and NETShould you be buying Genesis Healthcare stock or one of its competitors? The main competitors of Genesis Healthcare include Autodesk (ADSK), Atlassian (TEAM), Block (SQ), NetEase (NTES), Datadog (DDOG), Snowflake (SNOW), Electronic Arts (EA), HubSpot (HUBS), Veeva Systems (VEEV), and Cloudflare (NET). These companies are all part of the "prepackaged software" industry. Genesis Healthcare vs. Autodesk Atlassian Block NetEase Datadog Snowflake Electronic Arts HubSpot Veeva Systems Cloudflare Autodesk (NASDAQ:ADSK) and Genesis Healthcare (NYSE:GEN) are both large-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, media sentiment, analyst recommendations, risk and community ranking. Does the MarketBeat Community prefer ADSK or GEN? Autodesk received 768 more outperform votes than Genesis Healthcare when rated by MarketBeat users. Likewise, 69.27% of users gave Autodesk an outperform vote while only 65.56% of users gave Genesis Healthcare an outperform vote. CompanyUnderperformOutperformAutodeskOutperform Votes124269.27% Underperform Votes55130.73% Genesis HealthcareOutperform Votes47465.56% Underperform Votes24934.44% Do insiders and institutionals hold more shares of ADSK or GEN? 90.2% of Autodesk shares are held by institutional investors. Comparatively, 82.1% of Genesis Healthcare shares are held by institutional investors. 0.1% of Autodesk shares are held by company insiders. Comparatively, 3.3% of Genesis Healthcare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is ADSK or GEN more profitable? Autodesk has a net margin of 18.21% compared to Genesis Healthcare's net margin of 17.83%. Genesis Healthcare's return on equity of 155.48% beat Autodesk's return on equity.Company Net Margins Return on Equity Return on Assets Autodesk18.21% 59.41% 12.17% Genesis Healthcare 17.83%155.48%9.12% Which has better valuation & earnings, ADSK or GEN? Autodesk has higher revenue and earnings than Genesis Healthcare. Genesis Healthcare is trading at a lower price-to-earnings ratio than Autodesk, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAutodesk$5.50B12.04$906M$4.8962.95Genesis Healthcare$2.80B6.73$836M$0.9032.71 Does the media prefer ADSK or GEN? In the previous week, Autodesk had 39 more articles in the media than Genesis Healthcare. MarketBeat recorded 44 mentions for Autodesk and 5 mentions for Genesis Healthcare. Autodesk's average media sentiment score of 0.93 beat Genesis Healthcare's score of 0.00 indicating that Autodesk is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Autodesk 23 Very Positive mention(s) 0 Positive mention(s) 15 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Genesis Healthcare 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility and risk, ADSK or GEN? Autodesk has a beta of 1.47, indicating that its stock price is 47% more volatile than the S&P 500. Comparatively, Genesis Healthcare has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500. Do analysts recommend ADSK or GEN? Autodesk currently has a consensus price target of $302.38, suggesting a potential downside of 1.77%. Genesis Healthcare has a consensus price target of $30.20, suggesting a potential upside of 2.58%. Given Genesis Healthcare's higher probable upside, analysts plainly believe Genesis Healthcare is more favorable than Autodesk.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Autodesk 0 Sell rating(s) 8 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 2.67Genesis Healthcare 0 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.40 SummaryAutodesk beats Genesis Healthcare on 16 of the 19 factors compared between the two stocks. Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Get Genesis Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for GEN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GEN vs. The Competition Export to ExcelMetricGenesis HealthcarePrepackaged software IndustryBusiness SectorNYSE ExchangeMarket Cap$18.82B$25.01B$6.92B$19.90BDividend Yield3.05%2.32%2.92%3.54%P/E Ratio32.7190.6445.3042.67Price / Sales6.738.09203.6018.14Price / Cash8.4287.3924.3317.85Price / Book-184.0011.015.085.60Net Income$836M$444.73M$120.92M$985.93M Genesis Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GENGenesis Healthcare1.1904 of 5 stars$29.44+0.7%$30.20+2.6%+41.6%$18.82B$2.80B32.712,700Ex-DividendADSKAutodesk4.3765 of 5 stars$307.84+0.9%$302.38-1.8%+40.1%$66.19B$5.50B62.9514,100Upcoming EarningsAnalyst ForecastTEAMAtlassian4.1398 of 5 stars$245.45-0.9%$244.21-0.5%+31.9%$64.52B$4.36B0.0012,157Insider TradeSQBlock3.8383 of 5 stars$89.69-3.0%$91.18+1.7%+51.4%$57.28B$21.92B50.3912,985Analyst DowngradeNTESNetEase4.4756 of 5 stars$87.53+2.2%$107.29+22.6%-26.1%$55.02B$14.57B14.7929,128Dividend AnnouncementDDOGDatadog4.7404 of 5 stars$135.45+1.5%$150.96+11.5%+21.2%$45.32B$2.13B255.575,200Analyst ForecastInsider TradeSNOWSnowflake4.7444 of 5 stars$129.12-0.9%$171.59+32.9%-22.6%$43.66B$2.81B0.007,004Analyst ForecastNews CoverageHigh Trading VolumeEAElectronic Arts4.2945 of 5 stars$166.71+0.3%$165.37-0.8%+23.1%$43.57B$7.56B42.8613,700Insider TradeHUBSHubSpot4.2387 of 5 stars$695.00+1.8%$672.68-3.2%+46.2%$35.23B$2.17B0.007,663Insider TradeVEEVVeeva Systems4.7385 of 5 stars$210.63+0.4%$236.92+12.5%+17.8%$33.99B$2.36B56.177,172Analyst ForecastNETCloudflare3.8202 of 5 stars$96.47+0.1%$92.88-3.7%+32.5%$33.07B$1.30B0.003,682Insider Trade Related Companies and Tools Related Companies ADSK Alternatives TEAM Alternatives SQ Alternatives NTES Alternatives DDOG Alternatives SNOW Alternatives EA Alternatives HUBS Alternatives VEEV Alternatives NET Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:GEN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | SponsoredJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purpose...Priority Gold | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredTrump said you could learn something from this manEarly Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide vic...Wide Moat Research | SponsoredThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of ...WealthPress | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genesis Healthcare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genesis Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GEN Stock Alerts